The m6A quantitative analysis showed that the METTL3 and METTL14 KD decreased the total m6A modification level in glioma cells, whereas the YTHDC1 KD did not (Additional file 11: Fig. S9D). This evidence concerns the gene METTL14 and central nervous system cancer.